Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular immune response to human immunodeficiency virus.

P J Norris1, E S Rosenberg

  • 1Partners AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital and Harvard Medical School, Boston 02144, USA.

AIDS (London, England)
|June 27, 2001
PubMed
Summary

Effective HIV-1 control may rely on boosting immune responses, not just therapy. Early treatment can restore critical T-cell functions, suggesting new immunotherapeutic strategies for HIV management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Declines in Pregnancies among U.S. Adolescents from 2007 to 2017: Behavioral Contributors to the Trend.

Journal of pediatric and adolescent gynecology·2022
Same author

Risk factors for sporadic Giardia infection in the USA: a case-control study in Colorado and Minnesota.

Epidemiology and infection·2018
Same author

Manufacturing method affects mitochondrial DNA release and extracellular vesicle composition in stored red blood cells.

Vox sanguinis·2016
Same author

Improving influenza and Tdap vaccination during pregnancy: A cluster-randomized trial of a multi-component antenatal vaccine promotion package in late influenza season.

Vaccine·2015
Same author

The effect of processing method on the in vitro characteristics of red blood cell products.

Vox sanguinis·2015
Same author

Measures to prevent transfusion-related acute lung injury (TRALI).

Vox sanguinis·2012

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Highly active antiretroviral therapy (HAART) has improved HIV-1 management but cannot eradicate the virus.
  • Focus is shifting towards immune-based strategies for controlling HIV-1 replication.
  • Correlates of immune protection against HIV-1 are not fully understood, but cellular immunity is implicated.

Purpose of the Study:

  • To investigate the role of HIV-1-specific cellular immune responses in viral control.
  • To explore the potential of immunotherapeutic approaches for augmenting HIV-1-specific immunity.

Main Methods:

  • Analysis of T-helper cell and cytotoxic T-lymphocyte responses in different HIV-1 infection stages.
  • Evaluation of immune responses following treatment during acute HIV-1 seroconversion.

Related Experiment Videos

  • Review of evidence linking immune responses to viral replication control.

    • Main Results:

    • Vigorous HIV-1-specific CD4+ T-helper and CD8+ cytotoxic T-lymphocyte responses are associated with viral control in nonprogressive infection.
    • In chronic progressive HIV-1 infection, T-helper responses are often weak or absent, leading to diminished cytotoxic T-lymphocyte activity.
    • Treatment during acute HIV-1 seroconversion can restore HIV-1-specific T-helper cell responses.

    Conclusions:

    • HIV-1-specific cellular immunity, particularly T-helper cell responses, is crucial for controlling viral replication.
    • Restoring HIV-1-specific T-helper cell responses, potentially through early treatment or immunotherapy, is a promising strategy.
    • Structured treatment interruption and immunotherapeutics may offer new avenues for managing HIV-1 infection by enhancing immune control.